Clinical Trial Update: Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates gevokizumab in combination with standard-of-care anticancer therapies for metastatic colorectal cancer, gastroesophageal cancer, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastroesophageal Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Gevokizumab (gevokizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Colorectal Cancer, Gastroesophageal Cancer | Phase 1 | Status: COMPLETED